Adela Maria Serrano Gimeno-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

    Medicina (Lithuania), Vol. 59, Núm. 10

2022

  1. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen, Vol. 48, Núm. 4, pp. 275-292

  2. SEMERGEN positioning on approaching chronic heart failure in primary care

    Semergen, Vol. 48, Núm. 2, pp. 106-123

  3. The natriuretic peptides in the diagnosis of heart failure in primary care setting

    Semergen, Vol. 48, Núm. 7

2017

  1. Enfermedad renal crónica y dislipidemia

    Clinica e Investigacion en Arteriosclerosis

2016

  1. Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteración del metabolismo de la glucosa: Estudio Diana

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, Núm. 3, pp. 132-140

2015

  1. Resistant arterial hypertension in Primary Care patients in Spain. PRESCAP Study 2010

    Semergen, Vol. 41, Núm. 3, pp. 123-130

2012

  1. Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain

    Journal of Medical Economics, Vol. 15, Núm. SUPPL. 1, pp. 45-54